
Sign up to save your podcasts
Or


The topic discussed, which revolves around tests, imaging, and biomarkers related to prostate cancer, is particularly fascinating due to the variety of approaches available to monitor this disease before, during, or after treatment.
GUEST: Dr. Daniel Lewinshtein, Uro-Oncologist, Charles-Le Moyne Hospital.
HOSTED BY: Marie-Christine Beauchemin, Coordinator, Support Programs at PROCURE.
//
Le sujet de cet épisode est également disponible en français. Voir l'épisode #6: "Tests, imagerie et biomarqueurs".
By PROCUREThe topic discussed, which revolves around tests, imaging, and biomarkers related to prostate cancer, is particularly fascinating due to the variety of approaches available to monitor this disease before, during, or after treatment.
GUEST: Dr. Daniel Lewinshtein, Uro-Oncologist, Charles-Le Moyne Hospital.
HOSTED BY: Marie-Christine Beauchemin, Coordinator, Support Programs at PROCURE.
//
Le sujet de cet épisode est également disponible en français. Voir l'épisode #6: "Tests, imagerie et biomarqueurs".